Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Hemoperfusion in Severe and Critical Cases of COVID-19.
Alavi Darazam I, Kazempour M, Pourhoseingholi MA, Hatami F, Rabiei MM, Javandoust Gharehbagh F, Amirdosara M, Hajiesmaeili M, Shabani M, Shokouhi S, Lotfollahi L, Mardani M, Haghighi-Morad M, Nassiri AA, Rangraz D, Falahaty H, Syami H, Irannejad Y, Fallah M, Zangi M, Shafigh N. Alavi Darazam I, et al. Among authors: zangi m. Blood Purif. 2023;52(1):8-16. doi: 10.1159/000524606. Epub 2022 May 17. Blood Purif. 2023. PMID: 35580567 Free PMC article.
Study of the effects of interferon β-1a on hospitalized patients with COVID-19: SBMU Taskforce on the COVIFERON study.
Fallahzadeh M, Pourhoseingholi MA, Boroujeni MG, Besharati S, Mardani M, Shabani M, Shokouhi S, Amirdosara M, Hajiesmaeili M, Gachkar L, Roshan B, Zangi M, Mirmomeni G, Irvani SSN, Alavi Darazam I. Fallahzadeh M, et al. Among authors: zangi m. J Med Virol. 2022 Apr;94(4):1488-1493. doi: 10.1002/jmv.27475. Epub 2021 Nov 30. J Med Virol. 2022. PMID: 34821387 Free PMC article.
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.
Alavi Darazam I, Hatami F, Mahdi Rabiei M, Amin Pourhoseingholi M, Shabani M, Shokouhi S, Mardani M, Moradi O, Javandoust Gharehbagh F, Mirtalaee N, Negahban H, Amirdosara M, Zangi M, Hajiesmaeili M, Kazempour M, Shafigh N. Alavi Darazam I, et al. Among authors: zangi m. Int Immunopharmacol. 2021 Oct;99:107916. doi: 10.1016/j.intimp.2021.107916. Epub 2021 Jun 29. Int Immunopharmacol. 2021. PMID: 34224994 Free PMC article. Clinical Trial.